Tactile Systems Technology Inc. (TCMD) is an innovative medical technology company that is committed to providing superior quality home healthcare devices for people suffering from chronic diseases at home. The company designs, manufactures, and provides unique therapeutic devices which are primarily used for treating lymphedema, venous ulcers, and other chronic conditions.
The company was established in 1995 and has its headquarters in Minneapolis, Minnesota. To increase the quality of life for patients with chronic health issues, Tactile Systems Technology, Inc. leverages cutting-edge technology to develop and deliver groundbreaking medical equipment that helps patients manage their health conditions at home.
Tactile Systems Technology markets two main products: the Flexitouch system and the Entre System. The Flexitouch system is an advanced intermittent pneumatic compression device used for both lymphedema and nonhealing venous leg ulcers treatment. The Flexitouch system has proved highly beneficial in reducing swelling, improving mobility, and lessening recurrent infections related to lymphedema. On the other hand, the Entre System is a basic, easy-to-use pneumatic compression device for patients who are unsuitable for or have no access to the Flexitouch system.
The company operates with a niche focus on the lymphedema market and constantly keeps an eye out for new opportunities in the post-acute care landscape. Its patient-centered model and commitment to research and development have facilitated its continued growth and a strong market position.
Tactile Systems Technology also aims to raise awareness about lymphedema among medical professionals and patients. The company collaborates often with healthcare professionals and researchers to further its understanding of lymphedema and develop solutions that can provide optimum care and assistance to those affected by this condition.
The organization places a strong emphasis on values such as collaboration, integrity, innovation, and patient-orientation. They believe in providing comprehensive services that engage patients in their care and treatment process, improve their health outcomes, and optimize their quality of life. Tactile Systems Technology is a publicly-traded company and is listed on NASDAQ under the symbol TCMD.
In summary, Tactile Systems Technology, Inc. is a company that strives to make a meaningful difference in the lives of people living with chronic diseases. Through their commitment to innovation and a focused approach to comprehensive care, they enhance the overall quality and accessibility of treatment for lymphedema and other chronic conditions.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
First Light Asset Management LLC has acquired a new position in Tactile Systems Technology, Inc. (NASDAQ:TCMD), purchasing 462,562 shares valued at approximately $13.775 million. Other institutional investors like Goldman Sachs, Rhumbline Advisers, and American Century Companies also adjusted their holdings in the company. Tactile Systems Technology reported strong quarterly earnings, beating consensus estimates, and analysts have given the stock a "Moderate Buy" rating with a consensus target price of $38.40.
Tactile Systems Technology, Inc. (NASDAQ:TCMD) has received a "Moderate Buy" consensus rating from six brokerages, with an average 12-month price target of $38.40, significantly above its current trading price of $22.02. The company recently surpassed quarterly earnings and revenue expectations. While institutional ownership is high, CEO Sheri Dodd sold a portion of her shares to cover tax obligations related to vested equity awards.
Man Group plc has acquired 53,610 shares of Tactile Systems Technology, Inc. (NASDAQ:TCMD) in the second quarter, valuing its new position at approximately $1.6 million, representing a 0.24% stake in the company. Institutional investors now own 83.43% of the stock. Analysts currently rate TCMD with a consensus "Moderate Buy" and a price target of $38.40, following strong Q2 earnings that surpassed EPS estimates.
Empowered Funds LLC has invested $3.61 million in Tactile Systems Technology, Inc. (NASDAQ:TCMD), acquiring 121,116 shares and a 0.53% stake. The medical device company has a "Moderate Buy" consensus rating from analysts with an average price target of $38.40 and reported strong Q2 earnings, beating EPS estimates. Institutional investors collectively hold 83.43% of the company's stock.
Jupiter Topco LLC has acquired 397,278 shares of Tactile Systems Technology (NASDAQ:TCMD) worth approximately $11.8 million, representing a 1.75% stake in the company. Institutional investors now own 83.43% of the stock. Analysts generally maintain a "Moderate Buy" rating with an average price target of $38.40, following the company's recent strong quarterly earnings performance.
Paradigm Capital Management Inc. NY recently acquired a new stake of 229,199 shares in Tactile Systems Technology, Inc. (NASDAQ:TCMD), valued at approximately $6.83 million. Other institutional investors have also adjusted their holdings in the company, which currently sees 83.43% institutional ownership. CEO Sheri Louise Dodd also sold shares to cover tax obligations, while several analysts have issued "Buy" or "Hold" ratings with an average price target of $38.40.
Deutsche Bank AG recently acquired 172,782 shares of Tactile Systems Technology, Inc. (NASDAQ:TCMD) in the second quarter, valued at approximately $5.145 million, representing about 0.77% of the company's stock. Other institutional investors and hedge funds also adjusted their holdings, with Vanguard Group Inc. significantly increasing its stake. Concurrently, CEO Sheri Louise Dodd sold 10,978 shares, and several analysts have issued "Buy" or "Moderate Buy" ratings for TCMD, with a consensus target price of $38.40.
Globeflex Capital L P acquired a new stake of 222,298 shares in Tactile Systems Technology, Inc. (NASDAQ:TCMD) during the second quarter, valued at approximately $6.62 million. This purchase makes TCMD the 29th largest holding for Globeflex Capital L P, representing 0.8% of their total holdings. Other institutional investors also adjusted their positions in TCMD, while CEO Sheri Louise Dodd sold 10,978 shares to cover tax obligations.